Muscle wasting is a consequence of physiological changes or a pathology characterized by
increased catabolic activity that leads to progressive loss of skeletal muscle mass and …

Advanced cancer patients exhibit cachexia, a condition characterized by a significant
reduction in the body weight predominantly from loss of skeletal muscle and adipose tissue …

Cancer cachexia is a devastating, multifactorial and often irreversible syndrome that affects
around 50–80% of cancer patients, depending on the tumour type, and that leads to …

Cancer cachexia is a multifactorial syndrome characterized by an ongoing loss of skeletal
muscle mass, which negatively affects quality of life and portends a poor prognosis …

Background Cachexia is a multi-factorial, systemic syndrome that especially affects patients
with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival …

Cancer cachexia is a metabolic syndrome that can be present even in the absence of weight
loss ('precachexia'). Cachexia is often compounded by pre-existing muscle loss, and is …

Cancer cachexia is a severe and disabling clinical condition that frequently accompanies
the development of many types of cancer. Muscle wasting is the hallmark of cancer cachexia …

Cancer cachexia is characterized by a significant reduction in body weight resulting
predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced …

Cancer cachexia (CC) is a multifactorial syndrome characterized by systemic inflammation,
uncontrolled weight loss and dramatic metabolic alterations. This includes myofibrillar …

Muscle cachexia has a major detrimental impact on cancer patients, being responsible for
30% of all cancer deaths. It is characterized by a debilitating loss in muscle mass and …